Wright Medical says it's not optimistic about an FDA dispute resolution panel this May on its Augment biologic bone graft.
Wright Medical (NSDQ:WMGI) said it's not optimistic about an FDA dispute resolution panel on its Augment biologic bone graft product, now slated for May, and would quickly move to cut costs at the BioMimetic Therapeutics subsidiary it bought back in 2012.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1hb9MrY
Cap comentari:
Publica un comentari a l'entrada